Literature DB >> 1995727

Isolation and composition of the extracellular slime made by coagulase-negative staphylococci in a chemically defined medium.

M Hussain1, J G Hastings, P J White.   

Abstract

Slime isolated after growth of four strains of coagulase-negative staphylococci on chemically defined medium plus agar was rich in galactose. However, when sterile agar plates were extracted with saline, high-molecular-weight material with similar properties was obtained that also was galactose-rich. Most of the dry weight attributed to slime, and probably all the galactose, originated from agar. Slime isolated by gel and ion-exchange chromatography from liquid culture in the same medium contained glycerol phosphate, glucose (no galactose), glucosamine, alanine, uronate, an unidentified component, and protein. Separation of protein from carbohydrate was achieved by affinity chromatography. [14C]glucose in the medium labeled the carbohydrate polymer; [14C]amino acids chiefly labeled extracellular proteins. Slime from bacteria grown on medium solidified with silica gel or on dialysis membrane above an agar surface showed essentially the same composition and behavior after purification as the material isolated from liquid culture.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1995727     DOI: 10.1093/infdis/163.3.534

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

Review 1.  Pathogenesis of infections related to intravascular catheterization.

Authors:  D A Goldmann; G B Pier
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

2.  Activation of the human immunodeficiency virus long terminal repeat in THP-1 cells by a staphylococcal extracellular product.

Authors:  S J Klebanoff; F Kazazi; W C Van Voorhis; K G Schlechte
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

3.  Extracellular carbohydrate-containing polymers of a model biofilm-producing strain, Staphylococcus epidermidis RP62A.

Authors:  Irina Sadovskaya; Evgueny Vinogradov; Sigrid Flahaut; Grigorij Kogan; Saïd Jabbouri
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

4.  A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces.

Authors:  M Hussain; M Herrmann; C von Eiff; F Perdreau-Remington; G Peters
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

5.  Bacterial lipoteichoic acid enhances cryosurvival.

Authors:  Charles V Rice; Amy Middaugh; Jason R Wickham; Anthony Friedline; Kieth J Thomas; Erin Scull; Karen Johnson; Malcolm Zachariah; Ravindranth Garimella
Journal:  Extremophiles       Date:  2014-12-05       Impact factor: 2.395

6.  Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin.

Authors:  D Mack; M Nedelmann; A Krokotsch; A Schwarzkopf; J Heesemann; R Laufs
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Identification and characterization of a surface-associated protein (Ssp) of Staphylococcus saprophyticus.

Authors:  S Gatermann; B Kreft; R Marre; G Wanner
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

8.  Staphylococcal exopolysaccharides inhibit lymphocyte proliferative responses by activation of monocyte prostaglandin production.

Authors:  R D Stout; K P Ferguson; Y N Li; D W Lambe
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin.

Authors:  D McKenney; J Hübner; E Muller; Y Wang; D A Goldmann; G B Pier
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

Review 10.  Update on clinical significance of coagulase-negative staphylococci.

Authors:  W E Kloos; T L Bannerman
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.